David A. Siegel Nova Bay Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.18 - $0.31 $2,070 - $3,565	-11,500 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.27 - $0.4 $1,323 - $1,960	-4,900 Reduced 29.88%	11,500 $3,000
Q4 2021 Feb 14, 2022	BUY	$0.38 - $0.61 $6,232 - $10,004	16,400 New	16,400 $6,000
Q4 2019 Feb 14, 2020	SELL	$0.51 - $0.76 $10,098 - $15,048	-19,800 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.45 - $1.73 $8,910 - $34,254	19,800 New	19,800 $12,000

3.02K

Ticker NBY
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,988,400
Market Cap $144M
Description
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.